The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Lupin Australia Pty Limited
Regulatory activities for this sponsor.
Loading...
Sponsor content
550 result(s) found, displaying 391 to 400
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ABACAVIR/LAMIVUDINE LUPIN 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ABACAVIR/LAMIVUDINE LUPIN 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet bottle pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ABACAVIR/LAMIVUDINE LAPL 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ABACAVIR/LAMIVUDINE LAPL 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet bottle pack.
-
Prescription medicine registrationActive ingredients: ezetimibe; atorvastatin.
-
Prescription medicine registrationActive ingredients: phentermine.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TENOFOVIR EMT LAPL tenofovir disoproxil phosphate and emtricitabine 291mg/200mg film coated tablets.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TENOFOVIR GH tenofovir disoproxil phosphate 291 mg film-coated tablet.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TENOFOVIR LAPL tenofovir disoproxil phosphate 291 mg film-coated tablet.
-
Cancellation by sponsorRequested by Lupin Australia Pty Limited